Latest News & Features
Trademarks
Promoted leader wants to utilise AI for improving client experience | Brings expertise on strategic advice for international brands. 2 November 2023
Copyright Channel
Members of the UK’s Second Chamber are clued up on AI’s risks and want the government to move faster and further to address concerns. Marisa Woutersen speaks to the house's AI activists to find out more. 2 November 2023
Patents
Licensing firm launches its first Internet of Things programme | Licensors include Ericsson, Mitsubishi, Oppo and Siemens | Move follows Avanci’s successful automotive schemes | VP and head of IoT licensing speaks with WIPR. 1 November 2023
Patents
Finnish multinational accuses e-commerce giant and another tech company of ‘not playing by the rules’ | Dispute concerns video-related technology | Suits include a complaint filed at Unified Patent Court. 1 November 2023
Copyright
US district judge finds copyright infringement complaints to be “defective” | One claim of direct copyright infringement against StabilityAI allowed to proceed. 31 October 2023
Patents Channel
Criticism of the European Commission’s proposal to regulate standard-essential patents is mounting from prominent voices, making implementation look increasingly unlikely, finds Sarah Speight. 31 October 2023
Patents
Inventor’s patents ruled invalid after extensive quarrel with electronic signature company | Dispute stems from a case where the inventor was previously an expert witness for DocuSign. 30 October 2023
Trademarks Channel
A Dutch court’s decision leaves cause for concern for brand owners regarding online marketplaces' liability for trademark infringement, according to James Tumbridge, Robert Peake and Benedict Sharrock-Harris at Venner Shipley. 30 October 2023
Patents
Moves enhance the firm’s expertise in supercomputing, AI, biomedical engineering, life sciences, and pharma | Mathys also announces the additional promotion of four within the partnership across London and Cambridge. 30 October 2023
Patents
Apple faces US import ban and cease and desist order after violating Masimo's patents on blood oxygen tech | President has 60-day review period to veto. 27 October 2023
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.